Concepedia

Publication | Open Access

Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study

DOIFull Paper Access

69

Citations

41

References

2014

Year

Niklas Bergvall, Charles Makin, Raquel Lahoz, Neetu Agashivala, Ashish Pradhan, Gorana Capkun, Allison Petrilla, Swapna Karkare, Catherine B. McGuiness, Jonathan R. Korn
PLoS ONE

Abstract

In a real-world setting, patients with MS who switched from IFNs to fingolimod were significantly less likely to experience relapses than those who switched to GA.

References

YearCitations

Page 1